Literature DB >> 10593994

Mutations of the cathepsin C gene are responsible for Papillon-Lefèvre syndrome.

T C Hart1, P S Hart, D W Bowden, M D Michalec, S A Callison, S J Walker, Y Zhang, E Firatli.   

Abstract

Papillon-Lefèvre syndrome (PLS) is an autosomal recessive disorder characterised by palmoplantar hyperkeratosis and severe early onset periodontitis that results in the premature loss of the primary and secondary dentitions. A major gene locus for PLS has been mapped to a 2.8 cM interval on chromosome 11q14. Correlation of physical and genetic maps of this interval indicate it includes at least 40 ESTs and six known genes including the lysosomal protease cathepsin C gene (CTSC). The CTSC message is expressed at high levels in a variety of immune cells including polymorphonuclear leucocytes, macrophages, and their precursors. By RT-PCR, we found CTSC is also expressed in epithelial regions commonly affected by PLS, including the palms, soles, knees, and oral keratinised gingiva. The 4.7 kb CTSC gene consists of two exons. Sequence analysis of CTSC from subjects affected with PLS from five consanguineous Turkish families identified four different mutations. An exon 1 nonsense mutation (856C-->T) introduces a premature stop codon at amino acid 286. Three exon 2 mutations were identified, including a single nucleotide deletion (2692delA) of codon 349 introducing a frameshift and premature termination codon, a 2 bp deletion (2673-2674delCT) that results in introduction of a stop codon at amino acid 343, and a G-->A substitution in codon 429 (2931G-->A) introducing a premature termination codon. All PLS patients were homozygous for cathepsin C mutations inherited from a common ancestor. Parents and sibs heterozygous for cathepsin C mutations do not show either the palmoplantar hyperkeratosis or severe early onset periodontitis characteristic of PLS. A more complete understanding of the functional physiology of cathepsin C carries significant implications for understanding normal and abnormal skin development and periodontal disease susceptibility.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10593994      PMCID: PMC1734286     

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  17 in total

1.  Classification of autosomal dominant palmoplantar keratoderma: past-present-future.

Authors:  P H Itin
Journal:  Dermatology       Date:  1992       Impact factor: 5.366

2.  KERATOSIS PALMO-PLANTARIS CONGENITA, WITH PERIODONTOSIS, ARACHNODACTYLY AND A PECULIAR DEFORMITY OF THE TERMINAL PHALANGES.

Authors:  S HAIM; J MUNK
Journal:  Br J Dermatol       Date:  1965-01       Impact factor: 9.302

3.  Molecular cloning and sequence analysis of human preprocathepsin C.

Authors:  A Paris; B Strukelj; J Pungercar; M Renko; I Dolenc; V Turk
Journal:  FEBS Lett       Date:  1995-08-07       Impact factor: 4.124

4.  Molecular cloning, chromosomal localization, and expression of murine dipeptidyl peptidase I.

Authors:  C T Pham; R J Armstrong; D B Zimonjic; N C Popescu; D G Payan; T J Ley
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

5.  Clinical and immunological findings in 2 siblings with Papillon-Lefèvre syndrome.

Authors:  E Firatli; N Gürel; A Efeoglu; S Badur
Journal:  J Periodontol       Date:  1996-11       Impact factor: 6.993

Review 6.  [Osteoclasts in bone metabolism].

Authors:  Y Hakeda; M Kumegawa
Journal:  Kaibogaku Zasshi       Date:  1991-08

Review 7.  The Papillon-Lefèvre syndrome: keratosis palmoplantaris with periodontopathy. Report of a case and review of the cases in the literature.

Authors:  E Haneke
Journal:  Hum Genet       Date:  1979-09-02       Impact factor: 4.132

8.  Human dipeptidyl-peptidase I. Gene characterization, localization, and expression.

Authors:  N V Rao; G V Rao; J R Hoidal
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

9.  Oligomeric structure and substrate induced inhibition of human cathepsin C.

Authors:  I Dolenc; B Turk; G Pungercic; A Ritonja; V Turk
Journal:  J Biol Chem       Date:  1995-09-15       Impact factor: 5.157

10.  Papillon-Lefèvre syndrome. Analysis of neutrophil chemotaxis.

Authors:  E Firatli; B Tüzün; A Efeoğlu
Journal:  J Periodontol       Date:  1996-06       Impact factor: 6.993

View more
  73 in total

1.  Evidence of a founder effect for four cathepsin C gene mutations in Papillon-Lefèvre syndrome patients.

Authors:  Y Zhang; T Lundgren; S Renvert; D N Tatakis; E Firatli; C Uygur; P S Hart; M C Gorry; J J Marks; T C Hart
Journal:  J Med Genet       Date:  2001-02       Impact factor: 6.318

Review 2.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

3.  Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing.

Authors:  Chrystelle Bonnart; Céline Deraison; Matthieu Lacroix; Yoshikazu Uchida; Céline Besson; Aurélie Robin; Anaïs Briot; Marie Gonthier; Laurence Lamant; Pierre Dubus; Bernard Monsarrat; Alain Hovnanian
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

4.  Papillon-Lefevre Syndrome In An Adolescent Female: A Case Study.

Authors:  M J Jijin; H P Jaishankar; Veena Sathya Narayaran; Krupashankar Rangaswamy; Kavitha Ankanathapura Puthaswamy
Journal:  J Clin Diagn Res       Date:  2015-05-01

5.  Novel cathepsin C mutation in a Brazilian family with Papillon-Lefèvre syndrome: case report and mutation update.

Authors:  Debora Pallos; Ana Carolina Acevedo; Heliana Dantas Mestrinho; Ilia Cordeiro; Thomas C Hart
Journal:  J Dent Child (Chic)       Date:  2010 Jan-Apr

6.  Science is the fuel for the engine of technology and clinical practice.

Authors:  Malcolm L Snead; Harold C Slavkin
Journal:  J Am Dent Assoc       Date:  2009-09       Impact factor: 3.634

7.  A Pulmonary Perspective on GASPIDs: Granule-Associated Serine Peptidases of Immune Defense.

Authors:  George H Caughey
Journal:  Curr Respir Med Rev       Date:  2006-08

8.  Epstein-barr virus-induced changes in B-lymphocyte gene expression.

Authors:  Kara L Carter; Ellen Cahir-McFarland; Elliott Kieff
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 9.  Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).

Authors:  Brice Korkmaz; Adam Lesner; Stephanie Letast; Yassir K Mahdi; Marie-Lise Jourdan; Sandrine Dallet-Choisy; Sylvain Marchand-Adam; Christine Kellenberger; Marie-Claude Viaud-Massuard; Dieter E Jenne; Francis Gauthier
Journal:  Semin Immunopathol       Date:  2013-02-06       Impact factor: 9.623

10.  Papillon-Lefevre syndrome (PLS) without cathepsin C mutation: A rare early onset partially penetrant variant of PLS.

Authors:  Fayiza Yaqoob Khan; Suhail Majid Jan; Mubashir Mushtaq
Journal:  Saudi Dent J       Date:  2013-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.